Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Trial ID or NCT#
NCT04579588
Status
RECRUITING
Purpose
The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 13 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Official Title
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Eligibility Criteria
Ages Eligible for Study: 13 Years to 64 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
- * Age 13 through 64 years* Diagnosed with COVID-19 at least 2 months prior enrollment* Patients with or without obesity, diabetes, chronic fatigue and/or long term COVID-19 symptoms* Patients without COVID-19 diagnosis for controls
Exclusion Criteria:
- * Received the influenza vaccine less than 4 months ago* Pregnant or lactating* Patients with special risks attendant to venipuncture* Use of immunomodulatory medications* Immunodeficiency or autoimmune disease
Investigator(s)
Sayantani Sindher
Allergist,
Immunologist
Clinical Associate Professor, Medicine
Clinical Associate Professor, Pediatrics - Allergy and Clinical Immunology
Contact us to find out if this trial is right for you.
Contact
SNP Center Inquiry
(650) 521-7237
View on ClinicalTrials.gov
